Citation Tools

Download PDFPDF

Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis

Download to a citation manager

Cite this article as:
Tanaka Y, Fautrel B, Keystone EC, et al
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis